GENB logo

GENB
Generate Biomedicines Inc

124
Mkt Cap
$1.98B
Volume
1.44M
52W High
$16.75
52W Low
$11.00
Price
$16.00
GENB Fundamentals
Prev Close
$15.47
Open
$15.25
50D MA
$12.84
Beta
0.00
Avg. Volume
344,217.24
EPS (Annual)
-$1.96
P/B
3.85
Rev/Employee
$102,221.15
Loading...
Loading...
News
all
press releases
Generate Biomedicines, Inc. Reports First Quarter 2026 Financial Results and Provides Business Update
Generate Biomedicines, Inc. Reports First Quarter 2026 Financial Results and Provides Business Update Generate Biomedicines, Inc. Reports First Quarter 2026 Financial Results and Provides Business Update PR Newswire SOMERVILLE, Mass., May 7, 2026 SOLAIRIA-1 AND SOLAIRIA-2 Phase 3 clinical trials...
PR Newswire·9d ago
News Placeholder
More News
News Placeholder
Generate Biomedicines (NASDAQ:GENB) Hits New 1-Year High - Should You Buy?
Generate Biomedicines (NASDAQ:GENB) Reaches New 52-Week High - Time to Buy...
MarketBeat·10d ago
News Placeholder
Generate Biomedicines (NASDAQ:GENB) Trading Up 8.1% - Should You Buy?
Generate Biomedicines (NASDAQ:GENB) Shares Up 8.1% - Still a Buy...
MarketBeat·11d ago
News Placeholder
Generate Biomedicines Inc (NASDAQ:GENB) Given Consensus Rating of "Moderate Buy" by Analysts
Generate Biomedicines Inc (NASDAQ:GENB - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the seven analysts that are covering the stock, Marketbeat Ratings...
MarketBeat·28d ago
News Placeholder
Research Analysts Set Expectations for GENB Q1 Earnings
Generate Biomedicines Inc (NASDAQ:GENB - Free Report) - Stock analysts at HC Wainwright issued their Q1 2026 earnings estimates for Generate Biomedicines in a report issued on Monday, April 13th. HC...
MarketBeat·1mo ago
News Placeholder
Generate Biomedicines (NASDAQ:GENB) Shares Up 7% - What's Next?
Generate Biomedicines (NASDAQ:GENB) Trading Up 7% - Time to Buy...
MarketBeat·1mo ago
News Placeholder
Generate Biomedicines (NASDAQ:GENB) Coverage Initiated by Analysts at HC Wainwright
HC Wainwright initiated coverage on Generate Biomedicines in a research note on Monday. They issued a "buy" rating and a $16.00 price objective on the stock...
MarketBeat·1mo ago
News Placeholder
Generate Biomedicines (NASDAQ:GENB) Trading Down 6.9% - Time to Sell?
Generate Biomedicines (NASDAQ:GENB) Shares Down 6.9% - Time to Sell...
MarketBeat·1mo ago
News Placeholder
Generate Biomedicines Inc's Quiet Period To End on April 8th (NASDAQ:GENB)
Generate Biomedicines' (NASDAQ:GENB - Get Free Report) quiet period will end on Wednesday, April 8th. Generate Biomedicines had issued 25,000,000 shares in its IPO on February 27th. The total size of...
MarketBeat·1mo ago
News Placeholder
Generate Biomedicines Inc (NASDAQ:GENB) Receives Consensus Recommendation of "Buy" from Analysts
Generate Biomedicines Inc (NASDAQ:GENB - Get Free Report) has received an average recommendation of "Buy" from the five ratings firms that are presently covering the firm, MarketBeat Ratings reports. Five equities research analysts have rated the stock with a buy recommendation. The average 1-year...
MarketBeat·2mo ago
<
1
2
...
>

Latest GENB News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.